Dogwood Therapeutics Inc. (DWTX)

AI Score

Unlock

5.51

-0.15 (-2.65%)

At close: Apr 25, 2025, 3:59 PM

5.55

0.73%

After-hours: Apr 25, 2025, 05:44 PM EDT

Dogwood Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q4 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Dec 31, 2019
Cash & Equivalents	14.85M	2.04M	3.02M	2.38M	3.32M	4.79M	4.59M	5.33M	7.03M	9.79M	7.7M	11.35M	14.01M	19.19M	21.84M	24.59M	29.8M	499.08K	1.05M	309.38K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	18.13K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	225.28K	60K	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	324.00	n/a	n/a	785.00
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	28.01K	20.84K	35.07K	52.24K	3.56K	18.82K	32.11K	53.91K	7.29K	13.68K	25.38K	34.07K	863.00	21.08K	757.00	n/a	n/a	n/a	n/a	n/a
Total Current Assets	16.54M	2.28M	3.64M	3.22M	4.17M	5.25M	5.21M	6.52M	8.37M	10.86M	9.04M	12.55M	15.78M	20.11M	23.76M	28.27M	31.47M	560.1K	1.21M	315.9K
Property-Plant & Equipment	222.65K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	77.52M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	77.76M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	225.28K	60K	n/a
Total Assets	94.31M	2.28M	3.64M	3.22M	4.17M	5.25M	5.21M	6.52M	8.37M	10.86M	9.04M	12.55M	15.78M	20.11M	23.76M	28.27M	31.47M	785.37K	1.27M	315.9K
Account Payables	1.23M	454.96K	217.76K	196.76K	111.91K	205.37K	214.31K	135.09K	573.16K	679.42K	665.54K	330.69K	353.86K	483.5K	262.59K	614.66K	368.9K	199.37K	198.25K	35.42K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	44.19K	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	737.28K	n/a	55.92K	93.97K	n/a	46.8K	62.73K	93.15K	159.7K	261.35K	346.5K	236.85K	532.68K	459.06K	345.31K	226.93K	573.48K	34.65K	19.52K	n/a
Total Current Liabilities	3.18M	1.33M	500.08K	570.08K	358.55K	487.14K	520.03K	549.29K	1.04M	1.63M	1.9M	1.88M	1.28M	1.23M	906.26K	1.17M	1.53M	1.78M	1.85M	1.62M
Long-Term Debt	15.38M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	4.15M	5.49M	3.64M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	26.85M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	4.15M	5.49M	3.64M
Total Liabilities	30.03M	1.33M	500.08K	570.08K	358.55K	487.14K	520.03K	549.29K	1.04M	1.63M	1.9M	1.88M	1.28M	1.23M	906.26K	1.17M	1.53M	5.94M	7.34M	5.26M
Total Debt	15.59M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	4.15M	5.49M	3.64M
Common Stock	133.00	111.00	2.78K	1.93K	77.00	1.93K	1.86K	1.83K	1.83K	1.83K	833.00	833.00	833.00	833.00	833.00	833.00	830.00	16.24M	12.6M	12.6M
Retained Earnings	-73.82M	-66.09M	-63.81M	-62.76M	-61.47M	-60.37M	-59.13M	-57.69M	-56.17M	-54.13M	-51.55M	-47.89M	-43.93M	-39.41M	-35.3M	-31.02M	-27.97M	-21.46M	-18.74M	-17.62M
Comprehensive Income	-3.86M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	64.28M	949.43K	3.14M	2.65M	3.81M	4.76M	4.69M	5.97M	7.33M	9.22M	7.14M	10.67M	14.5M	18.88M	22.86M	27.11M	29.94M	-5.15M	-6.06M	-4.94M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a